A meta-analysis and systematic review evaluating the use of erythropoietin in total hip and knee arthroplasty

Reference

• TranDHDWongGTCheeYEIrwinMGEffectiveness and safety of erythropoiesis-stimulating agent use in the perioperative periodExpert Opin Biol Ther2014141516124219367
   PubMed Web of Science ®Google Scholar
• ZhaoYJiangCPengHFengBLiYWengXThe effectiveness and safety of preoperative use of erythropoietin in patients scheduled for total hip or knee arthroplastyMedicine20169527e412227399121
   PubMed Web of Science ®Google Scholar
• VoornVMAvan der HoutASo-OsmanCErythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplastyVox Sang2016111321922527314459
   PubMed Web of Science ®Google Scholar
• AlsalehKAlotaibiGSAlmodaimeghHSAleemAAKouroukisCTThe use of preoperative erythropoiesis-stimulating agents (ESAs) in patients who underwent knee or hip arthroplastyJ Arthroplasty20132891463147223528548
   PubMed Web of Science ®Google Scholar
• StivelmanJCTarget-based anemia management with erythropoiesis stimulating agents (risks and benefits relearned) and iron (still more to learn)Semin Dial201730214214828083917
   PubMed Web of Science ®Google Scholar
• ElliottSTomitaDEndreZErythropoiesis stimulating agents and reno-protection: a meta-analysisBMC Nephrol20171811428077085
   PubMed Web of Science ®Google Scholar
• FoleyRNEmerging erythropoiesis-stimulating agentsNat Rev Nephrol20106421822320177399
   PubMed Web of Science ®Google Scholar
• MaresJMFoleyLSBellMTErythropoietin activates the phosporylated cAMP [adenosine 3′5′ cyclic monophosphate] response element-binding protein pathway and attenuates delayed paraplegia after ischemia-reperfusion injuryJ Thorac Cardiovasc Surg2015149392092425500291
   PubMed Web of Science ®Google Scholar
• YamanakaKEldeiryMAftabMOptimized induction of beta common receptor enhances the neuroprotective function of erythropoietin in spinal cord ischemic injuryJ Thorac Cardiovasc Surg Epub292018
   Web of Science ®Google Scholar
• SmithPDPuskasFFullertonDAAttenuation of spinal cord ischemia and reperfusion injury by erythropoietinJ Thorac Cardiovasc Surg2011141125626021168028
   PubMed Web of Science ®Google Scholar
• RobertsonCSHannayHJYamalJMEffect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injuryJAMA201431213625058216
   PubMed Web of Science ®Google Scholar
• Gonzalez-PorrasJRColadoECondeMPLopezTNietoMJCorralMAn individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplastyTransfus Med2009191354219302453
   PubMed Web of Science ®Google Scholar
• HillGEFrawleyWHGriffithKEForestnerJEMineiJPAllogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysisJ Trauma200354590891412777903
   PubMedGoogle Scholar
• KeatingEMRitterMATransfusion options in total joint arthroplastyJ Arthroplasty2002174 Suppl 112512812068422
   PubMed Web of Science ®Google Scholar
• KeatingEMCallaghanJJRanawatASBhirangiKRanawatCSA randomized, parallel-group, open-label trial of recombinant human erythropoietin vs preoperative autologous donation in primary total joint arthroplastyJ Arthroplasty200722332533317400086
   PubMed Web of Science ®Google Scholar
• JansØJørgensenCKehletHJohanssonPILundbeck Foundation Centre for Fast-track Hip and Knee Replacement Collaborative GroupRole of preoperative anemia for risk of transfusion and postoperative morbidity in fast-track hip and knee arthroplastyTransfusion201454371772623829298
   PubMed Web of Science ®Google Scholar
• JorgensenCCKehletHLundbeck Foundation Centre for Fast-track Hip and Knee replacement collaborative groupEarly thromboembolic events #1 week after fast-track total hip and knee arthroplastyThromb Res2016138374226826506
   PubMed Web of Science ®Google Scholar
• AndersonFAJrSpencerFARisk factors for venous thromboembolismCirculation200310790231I9I1612814980
   PubMed Web of Science ®Google Scholar
• Bernabeu-WittelMRomeroMOllero-BaturoneMFerric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trialTransfusion20165692199221127195774
   PubMed Web of Science ®Google Scholar
• So-OsmanCNelissenRGKoopman-van GemertAWPatient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patientsAnesthesiology2014120483985124424070
   PubMed Web of Science ®Google Scholar
• BuljanMNemetDGolubic-CepulicBBicanicGTripkovicBDelimarDTwo different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplastyInt Orthop201236470370921964703
   PubMed Web of Science ®Google Scholar
• NaHSShinSYHwangJYJeonYTKimCSDoSHEffects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty (CME)Transfusion201151111812420624257
   PubMed Web of Science ®Google Scholar
• MoonenAFThomassenBJKnoorsNTvan OsJJVerburgADPilotPPre-operative injections of epoetin-alpha versus post-operative retransfusion of autologous shed blood in total hip and knee replacement: a prospective randomised clinical trialJ Bone Joint Surg Br20089081079108318669967
   PubMedGoogle Scholar
• DeutschASpauldingJMarcusREPreoperative epoetin alfa vs autologous blood donation in primary total knee arthroplastyJ Arthroplasty200621562863516877146
   PubMed Web of Science ®Google Scholar
• RosencherNPoissonDAlbiAAperceMBarréJSamamaCMTwo injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic surgeryCan J Anaesth200552216016515684256
   PubMed Web of Science ®Google Scholar
• WeberEWSlappendelRHémonYEffects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST)Eur J Anaesthesiol200522424925715892401
   PubMed Web of Science ®Google Scholar
• HardwickMEMorrisBMColwellCWJrTwo-dose epoetin alfa reduces blood transfusions compared with autologous donationClin Orthop Relat Res2004423240244
   Web of Science ®Google Scholar
• AvallAHyllnerMBengtsonJPCarlssonLBengtssonARecombinant human erythropoietin in preoperative autologous blood donation did not influence the haemoglobin recovery after surgeryActa Anaesthesiol Scand200347668769212803585
   PubMed Web of Science ®Google Scholar
• BezwadaHPNazarianDGHenryDHBoothREJrPreoperative use of recombinant human erythropoietin before total joint arthroplastyJ Bone Joint Surg Am200385-A91795180012954840
   PubMed Web of Science ®Google Scholar
• AksoyMCTokgozogluAMErythropoietin for autologous blood donation in total hip arthroplasty patientsArch Orthop Trauma Surg2001121316216511262783
   PubMed Web of Science ®Google Scholar
• OlijhoekGMegensJGMustoPRole of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trialTransfusion200141795796311452166
   PubMed Web of Science ®Google Scholar
• GombotzHGriesMSipurzynskiSFruhwaldSRehakPPreoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacementActa Anaesthesiol Scand200044673774210903019
   PubMed Web of Science ®Google Scholar
• FeaganBGWongCJKirkleyAErythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trialAnn Intern Med20001331184585411103054
   PubMed Web of Science ®Google Scholar
• FarisPMRitterMAAbelsRIThe effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operationJ Bone Joint Surg Am199678162728550681
   PubMed Web of Science ®Google Scholar
• HasegawaYTakamatsuJIwaseTIwasadaSKitamuraSIwataHEffects of recombinant human erythropoietin on thrombosis and fibrinolysis in autologous transfusion for hip surgeryArch Orthop Trauma Surg19991197–838438710613225
   PubMed Web of Science ®Google Scholar
• WurnigCSchatzKNoskeHSubcutaneous low-dose epoetin beta for the avoidance of transfusion in patients scheduled for elective surgery not eligible for autologous blood donationEur Surg Res2001335–630331011805389
   PubMed Web of Science ®Google Scholar
• StowellCPChandlerHJovéMGuilfoyleMWacholtzMCAn open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplastyOrthopedics199922Suppl 1s105s1129927110
   PubMed Web of Science ®Google Scholar
• MercurialiFEpoetin alfa increases the volume of autologous blood donated by patients scheduled to undergo orthopedic surgerySemin Hematol1996332 Suppl 21014
   Web of Science ®Google Scholar
• PriceTHGoodnoughLTVoglerWRThe effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trialTransfusion199636129368607150
   PubMed Web of Science ®Google Scholar
• GoodnoughLTPriceTHFriedmanKDA phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacyTransfusion199434166718273133
   PubMed Web of Science ®Google Scholar
• BerisPMermillodBLevyGRecombinant human erythropoietin as adjuvant treatment for autologous blood donation. A prospective studyVox Sang19936532122188249364
   PubMed Web of Science ®Google Scholar
• Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Canadian Orthopedic Perioperative Erythropoietin Study GroupLancet19933418855122712328098389
   PubMed Web of Science ®Google Scholar